End-of-day quote
Taipei Exchange
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
21.1
TWD
|
-0.94%
|
|
+9.90%
|
+106.86%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,491
|
1,994
|
6,058
|
1,607
|
1,553
|
1,276
|
Enterprise Value (EV)
1 |
1,738
|
1,946
|
6,547
|
2,097
|
1,579
|
1,311
|
P/E ratio
|
-5.82
x
|
-6.61
x
|
-38
x
|
-4.5
x
|
-5.17
x
|
-5.03
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.82
x
|
2.47
x
|
4.9
x
|
1.44
x
|
1.73
x
|
1.55
x
|
EV / Revenue
|
2.12
x
|
2.41
x
|
5.3
x
|
1.88
x
|
1.76
x
|
1.59
x
|
EV / EBITDA
|
-15.8
x
|
-23.1
x
|
-151
x
|
-5.89
x
|
-12
x
|
-17.3
x
|
EV / FCF
|
-8.78
x
|
-11.6
x
|
-216
x
|
42.5
x
|
-10.9
x
|
1,340
x
|
FCF Yield
|
-11.4%
|
-8.65%
|
-0.46%
|
2.35%
|
-9.21%
|
0.07%
|
Price to Book
|
2.22
x
|
1.98
x
|
7.01
x
|
2.93
x
|
1.65
x
|
1.85
x
|
Nbr of stocks (in thousands)
|
65,619
|
85,863
|
86,382
|
87,002
|
147,218
|
147,218
|
Reference price
2 |
22.72
|
23.22
|
70.13
|
18.48
|
10.55
|
8.670
|
Announcement Date
|
4/30/18
|
4/30/19
|
4/30/20
|
4/29/21
|
4/29/22
|
5/2/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
820.5
|
807.5
|
1,236
|
1,114
|
898.1
|
825.4
|
EBITDA
1 |
-109.9
|
-84.4
|
-43.47
|
-355.8
|
-131.6
|
-75.58
|
EBIT
1 |
-225.6
|
-199.1
|
-155.9
|
-480.5
|
-258.7
|
-190.7
|
Operating Margin
|
-27.5%
|
-24.66%
|
-12.61%
|
-43.15%
|
-28.81%
|
-23.11%
|
Earnings before Tax (EBT)
1 |
-234.6
|
-265.4
|
-180.5
|
-529.1
|
-293.2
|
-253.6
|
Net income
1 |
-234.4
|
-265.4
|
-158.9
|
-354.8
|
-293.2
|
-253.6
|
Net margin
|
-28.56%
|
-32.87%
|
-12.86%
|
-31.86%
|
-32.65%
|
-30.73%
|
EPS
2 |
-3.907
|
-3.513
|
-1.847
|
-4.103
|
-2.040
|
-1.723
|
Free Cash Flow
1 |
-197.9
|
-168.4
|
-30.24
|
49.3
|
-145.4
|
0.9782
|
FCF margin
|
-24.12%
|
-20.86%
|
-2.45%
|
4.43%
|
-16.18%
|
0.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/18
|
4/30/19
|
4/30/20
|
4/29/21
|
4/29/22
|
5/2/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
247
|
-
|
489
|
490
|
25.7
|
34.2
|
Net Cash position
1 |
-
|
47.2
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-2.247
x
|
-
|
-11.26
x
|
-1.377
x
|
-0.195
x
|
-0.4529
x
|
Free Cash Flow
1 |
-198
|
-168
|
-30.2
|
49.3
|
-145
|
0.98
|
ROE (net income / shareholders' equity)
|
-34.7%
|
-31.7%
|
-19.4%
|
-75.1%
|
-39.4%
|
-31.1%
|
ROA (Net income/ Total Assets)
|
-10.7%
|
-8.42%
|
-4.9%
|
-13.7%
|
-8.16%
|
-6.59%
|
Assets
1 |
2,194
|
3,153
|
3,246
|
2,588
|
3,594
|
3,846
|
Book Value Per Share
2 |
10.20
|
11.70
|
10.00
|
6.300
|
6.390
|
4.680
|
Cash Flow per Share
2 |
0.3600
|
1.570
|
1.000
|
1.210
|
1.850
|
1.910
|
Capex
1 |
87.2
|
79.9
|
231
|
108
|
116
|
31.5
|
Capex / Sales
|
10.62%
|
9.89%
|
18.66%
|
9.68%
|
12.87%
|
3.82%
|
Announcement Date
|
4/30/18
|
4/30/19
|
4/30/20
|
4/29/21
|
4/29/22
|
5/2/23
|
|
1st Jan change
|
Capi.
|
---|
| +106.86% | 95.22M | | +11.95% | 98.12B | | +9.69% | 38.82B | | -6.10% | 17.66B | | -20.02% | 2.24B | | -8.37% | 1.54B | | +29.63% | 1.23B | | -35.62% | 747M | | -35.36% | 735M | | -13.36% | 623M |
Glasses, Spectacles & Contact Lenses
|